Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKesson
Teva
McKinsey
Mallinckrodt
Accenture
Federal Trade Commission
UBS
Baxter

Generated: June 23, 2018

DrugPatentWatch Database Preview

YUTOPAR Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Yutopar patents expire, and when can generic versions of Yutopar launch?

Yutopar is a drug marketed by Astrazeneca and is included in two NDAs.

The generic ingredient in YUTOPAR is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
Summary for YUTOPAR
Drug patent expirations by year for YUTOPAR
Medical Subject Heading (MeSH) Categories for YUTOPAR
Synonyms for YUTOPAR
(+-)-erythro-1-(p-Hydroxyphenyl)-2-(2-(p-hydroxyphenyl)ethylamino)-1-propanol
(+-)-Ritodrine hydrochloride
(+/-)-erythro-1-(p-hydroxyphenyl)-2-[2-(p-hydroxyphenyl) ethylamino]-1-propanol hydrochloride
(1S,2R)-1-(4-hydroxyphenyl)-2-{[2-(4-hydroxyphenyl)ethyl]amino}propan-1-ol, ch loride
(R*,S*)-4-Hydroxy-alpha-(1-((2-(4-hydroxyphenyl)ethyl)amino)ethyl)benzyl alcohol hydrochloride
23239-51-2
239R512
4-(2-(((1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl)amino)ethyl)phenol hydrochloride
4-(2-{[1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)phenol hydrochloride
4-[(1S,2R)-1-hydroxy-2-{[2-(4-hydroxyphenyl)ethyl]amino}propyl]phenol hydrochloride
4-[2-[[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol hydrochloride
4-[2-[[(1S,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol hydrochloride
4-[2-[[(1S,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol;hydrochloride
4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenol hydrochloride
4-[2-[[1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol hydrochloride
52447-11-7
AB2000630
AC-3536
AC1L1M7N
AC1MI99N
AC1O7FJT
AC1Q3DRD
AKOS024374986
AKOS025117464
AN-12874
API0005741
AS-12194
BC200460
BCP0726000243
Benzenemethanol, 4-hydroxy-alpha-(1-((2-(4-hydroxyphenyl)ethyl)amino)ethyl)-, hydrochloride, (R*,S*)-
Benzenemethanol, 4-hydroxy-alpha-(1-((2-(4-hydroxyphenyl)ethyl)amino)ethyl)-, hydrochloride, (R*,S*)-(+-)-
Benzenemethanol, hydrochloride, (R*,S*)-
Benzyl alcohol, hydrochloride, erythro-
Benzyl alcohol, p-hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)-, hydrochloride, erythro-
Benzyl alcohol, p-hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)-, hydrochloride,erythro-
C17H21NO3.HCl
CAS-23239-51-2
CCG-220349
CCG-222345
CCG-39030
CHEBI:32102
CHEMBL1201160
CHEMBL1367605
CHEMBL1376064
CS-2563
CTK8G2972
D01263
DSSTox_CID_25438
DSSTox_GSID_45438
DSSTox_RID_80879
DTXSID00200447
DTXSID8045438
DU 21220; Miolene; NSC 291565
DU 21220;Miolene;NSC 291565;Pre-Par;Utemerin;Yutopar
DU-21220
DU21220
EINECS 245-514-8
erythro-p-Hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)benzyl alcohol hydrochloride
EU-0101041
FT-0630495
HMS1569E19
HMS1921L05
HY-B0452
J-015046
KS-000015I9
LP01041
LS-30765
LS-43012
LS-43013
MCULE-7606298853
MFCD01657514
Miolene
MLS000069561
MLS000859888
MLS001148127
MLS001333191
MLS001333192
MLS002153782
MLS006011162
MolPort-003-850-192
MolPort-003-959-434
N-(4-Hydroxyphenethyl)-4-hydroxynorephedrine Hydrochloride
N-(p-Hydroxyphenethyl)-4-hydroxynorephedrine hydrochloride
N-(p-Hydroxyphenylethyl)-4-hydroxynorephedrine Hydrochloride
N-[2-(p-Hydroxyphenyl)ethyl]-N-[2-(p-hydroxyphenyl)-2-hydroxy-1-methylethyl]amine Hydrochloride
NCGC00016773-01
NCGC00094326-01
NCGC00094912-01
NCGC00094912-02
NCGC00094912-03
NCGC00261726-01
NSC 291565
NSC-291565
NSC-757863
NSC291565
NSC757863
Opera_ID_1136
Pharmakon1600-01501149
Pre-Par
Prempar
Prestwick_763
R 0758
R0114
REGID_for_CID_3040551
ritodrin-hydrochloride
ritodrine
Ritodrine (hydrochloride)
RITODRINE HCL
RITODRINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER
Ritodrine hydrochloride
Ritodrine hydrochloride (JP17/USP)
Ritodrine hydrochloride (Yutopar)
Ritodrine hydrochloride [USAN:JAN]
Ritodrine hydrochloride [USAN:USP:JAN]
Ritodrine hydrochloride in dextrose 5% in plastic container
Ritodrine Hydrochloride, pharmaceutical secondary standard; traceable to USP, BP
Ritodrine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Ritodrinehydrochloride
s2533
SCHEMBL122631
SCHEMBL3677545
SCHEMBL3677546
SMR000058836
SMR000326750
SMR001233166
SPECTRUM1501149
SR-01000076101
SR-01000076101-2
ST51015115
Tox21_110603
Tox21_501041
UNII-ESJ56Q60GC component IDLSITKDRVDKRV-JSUROZADSA-N
UNII-ESJ56Q60GC component IDLSITKDRVDKRV-XHXSRVRCSA-N
Utopar
VU0239770-6
Yutopar (TN)

US Patents and Regulatory Information for YUTOPAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca YUTOPAR ritodrine hydrochloride TABLET;ORAL 018555-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for YUTOPAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astrazeneca YUTOPAR ritodrine hydrochloride TABLET;ORAL 018555-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Mallinckrodt
Farmers Insurance
Covington
Deloitte
Fuji
Dow
Colorcon
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.